| Smith-Lemli-Opitz Syndrome and Cholic Acid (NCT03720990) | University of Nebraska | 2021-03-27 |
| Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia (NCT05157802) | Teachers College, Columbia University | 2021-03-26 |
| Phase 1 Dose Escalation of ArtemiCoffee (NCT04805333) | Frederick R. Ueland, M.D. | 2021-03-26 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors (NCT04272034) | Incyte Corporation | 2021-03-26 |
| Enoxacin for Amyotrophic Lateral Sclerosis (ALS) (NCT04840823) | McGill University | 2021-03-26 |
| A Study to Investigate the PK and Safety of CKD-393 (NCT04768673) | Chong Kun Dang Pharmaceutical | 2021-03-26 |
| Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines (NCT04529538) | PATH | 2021-03-26 |
| Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 (NCT04954001) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2021-03-26 |
| Target Engagement of Terazosin in Healthy Adults (NCT04551040) | University of Iowa | 2021-03-26 |
| A Trial of Habit Formation Theory for Exercise in Older Adults (NCT04869644) | Northwell Health | 2021-03-26 |
| Pilot Study of 89-Zr Panitumumab in Pancreas Cancer (NCT04833959) | Stanford University | 2021-03-26 |
| Tolerability and Efficacy of RJX in Patients With COVID-19 (NCT04708340) | Reven Pharmaceuticals, Inc. | 2021-03-25 |
| Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects (NCT04802863) | Evopoint Biosciences Inc. | 2021-03-25 |
| A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia (NCT04836494) | CoA Therapeutics, Inc., a BridgeBio company | 2021-03-25 |
| Flucloxacillin as an Inducer of CYP-enzymes (NCT04840641) | University of Southern Denmark | 2021-03-25 |
| A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects (NCT04846998) | Boryung Pharmaceutical Co., Ltd | 2021-03-25 |
| Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects (NCT04699747) | Massachusetts General Hospital | 2021-03-25 |
| Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923 (NCT04805983) | Yale University | 2021-03-25 |
| A Study in Healthy Men to Find Out How BI 1015550 is Taken up and Handled by the Body (NCT04771286) | Boehringer Ingelheim | 2021-03-25 |
| Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults (NCT04776317) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-03-25 |
| A Study to Evaluate Camoteskimab in Participants With Still's Disease (NCT04752371) | Apollo Therapeutics Ltd | 2021-03-25 |
| Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome (NCT04850378) | University of Aarhus | 2021-03-25 |
| To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray (NCT04817800) | Humanis Saglık Anonim Sirketi | 2021-03-25 |
| Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream (NCT04807751) | LEO Pharma | 2021-03-25 |
| Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors (NCT04747470) | Gilead Sciences | 2021-03-25 |
| DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT04752163) | M.D. Anderson Cancer Center | 2021-03-25 |
| The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture (NCT04702516) | Morten Frost | 2021-03-24 |
| Synaptic Plasticity in the Epicardial Ganglionated Plexi (NCT05034419) | University of Oklahoma | 2021-03-24 |
| A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects (NCT04788017) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2021-03-24 |
| Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 (NCT04730427) | Genexine, Inc. | 2021-03-24 |
| Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors (NCT04665206) | Vivace Therapeutics, Inc | 2021-03-24 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION547 (NCT04934891) | Ionis Pharmaceuticals, Inc. | 2021-03-24 |
| A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects (NCT04793204) | Astellas Pharma China, Inc. | 2021-03-24 |
| Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors (NCT04931823) | Conjupro Biotherapeutics, Inc. | 2021-03-24 |
| Phase I Study of VLX-1005 in Healthy Subjects (NCT04783545) | Veralox Therapeutics | 2021-03-24 |
| The Behavioral Effects of Opioids and Alcohol (NCT04300751) | Sharon Walsh | 2021-03-24 |
| Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects (NCT04793295) | Tanabe Pharma America, Inc. | 2021-03-23 |
| A Phase 1 Dose Escalation and Expansion Study of AK117 (NCT04728334) | Akeso | 2021-03-23 |
| Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) (NCT04730635) | Merck Sharp & Dohme LLC | 2021-03-23 |
| A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors (NCT04761198) | Mereo BioPharma | 2021-03-23 |
| JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors (NCT04720976) | Allist Pharmaceuticals, Inc. | 2021-03-23 |
| A Study of XTR004 Radiotracer in Healthy Volunteers (NCT05195879) | Sinotau Pharmaceutical Group | 2021-03-23 |
| Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma (NCT04443829) | University College, London | 2021-03-23 |
| A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis) (NCT04817007) | Bristol-Myers Squibb | 2021-03-22 |
| Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088 (NCT04802057) | Bioverativ, a Sanofi company | 2021-03-22 |
| Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer (NCT04158349) | University of Utah | 2021-03-22 |
| To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers (NCT04767815) | Daewoong Pharmaceutical Co. LTD. | 2021-03-22 |
| CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma (NCT04758767) | CASI pharmaceuticals, Inc. | 2021-03-22 |
| Mass Balance Study of [14C] TAS-205 in Healthy Volunteers (NCT04825431) | Taiho Pharmaceutical Co., Ltd. | 2021-03-22 |
| A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors (NCT05302843) | Betta Pharmaceuticals Co., Ltd. | 2021-03-22 |
| Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (NCT04803708) | Technophage, SA | 2021-03-22 |
| Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs (NCT04286789) | Oryn Therapeutics, LLC | 2021-03-22 |
| MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma (NCT04798586) | Pfizer | 2021-03-22 |
| Pharmacokinetics, Safety, and Tolerability of SYN-020 (NCT04815993) | Theriva Biologics, Inc. | 2021-03-22 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects (NCT04802811) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-22 |
| A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects (NCT04809818) | Lumosa Therapeutics Co., Ltd. | 2021-03-21 |
| A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132 (NCT04755985) | Addpharma Inc. | 2021-03-21 |
| Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation (NCT04292184) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-03-21 |
| Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand (NCT04764422) | Mahidol University | 2021-03-20 |
| Evaluate the Safety, Tolerability and PK of HF1K16 in Healthy Volunteers (NCT05386823) | HighField Biopharmaceuticals Corporation | 2021-03-20 |
| A Study of ALS-4 in Healthy Adults Subjects (NCT05274802) | Aptorum International Limited | 2021-03-20 |
| A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors (NCT04731467) | Famewave Ltd. | 2021-03-19 |
| Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors (NCT04814004) | Kai Lin Xu; Jun Nian Zheng | 2021-03-19 |
| A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies (NCT04772989) | Arcus Biosciences, Inc. | 2021-03-19 |
| Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo (NCT04838080) | Kocak Farma | 2021-03-19 |
| Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors (NCT05382936) | Stemline Therapeutics, Inc. | 2021-03-19 |
| INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders (NCT04455841) | Incyte Corporation | 2021-03-19 |
| A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors (NCT04799054) | Ascendis Pharma Oncology Division A/S | 2021-03-18 |
| Effect of Acute Alcohol Intoxication on Neural Processes During Decisions to Engage in HIV Risk Behaviors (NCT04360018) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2021-03-18 |
| Study of Niacin in Glioblastoma (NCT04677049) | AHS Cancer Control Alberta | 2021-03-18 |
| Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers (NCT04776499) | Maastricht University | 2021-03-18 |
| Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects (NCT04486157) | HK inno.N Corporation | 2021-03-18 |
| Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer (NCT04837716) | M.D. Anderson Cancer Center | 2021-03-18 |
| The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC (NCT04839055) | Jiangnan University | 2021-03-18 |
| Pilot Study of an NTproBNP Guided Strategy of Cardioprotection (NCT04737265) | Abramson Cancer Center at Penn Medicine | 2021-03-18 |
| Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France) (NCT05038969) | Genuine Research Center, Egypt | 2021-03-18 |
| Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer (NCT04406857) | National Cancer Institute (NCI) | 2021-03-17 |
| Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer (NCT04938583) | CanariaBio Inc. | 2021-03-17 |
| The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection (NCT04766931) | Frontier Biotechnologies Inc. | 2021-03-17 |
| A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors (NCT04679038) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-17 |
| Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination (NCT03462212) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-03-17 |
| APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma (NCT04643405) | Ascentage Pharma Group Inc. | 2021-03-17 |
| A Study of LY3540378 in Healthy Participants (NCT04768855) | Eli Lilly and Company | 2021-03-17 |
| A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC (NCT04550104) | University of Leeds | 2021-03-17 |
| A Study to Investigate the Influence of Hepatic Impairment on Elpipodect (MK-8189) Treatment (MK-8189-012) (NCT04676425) | Merck Sharp & Dohme LLC | 2021-03-17 |
| Study of CT001 in Healthy Volunteers (NCT04807335) | Cessatech A/S | 2021-03-17 |
| PF-07284892 in Participants With Advanced Solid Tumors (NCT04800822) | Pfizer | 2021-03-17 |
| Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis (NCT04713475) | Gemma Biotherapeutics | 2021-03-17 |
| A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women (NCT04833127) | New York State Psychiatric Institute | 2021-03-17 |
| Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies (NCT04684472) | Liqun Zou | 2021-03-17 |
| Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery (NCT04609592) | Stanford University | 2021-03-17 |
| Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (NCT04817774) | Sangamo Therapeutics | 2021-03-17 |
| Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects. (NCT04775615) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-17 |
| Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer (NCT04892303) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-03-17 |
| Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis (NCT04785027) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2021-03-17 |
| Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration (NCT04790136) | SocraTec R&D GmbH | 2021-03-17 |
| Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans (NCT04711915) | Yale University | 2021-03-17 |
| Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer (NCT04608409) | Frederick R. Ueland, M.D. | 2021-03-17 |
| Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine (NCT04818515) | AbbVie | 2021-03-17 |
| Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer (NCT04487756) | Instituto Oncológico Dr Rosell | 2021-03-17 |